| Dr Thomas P Stern, MD | |
|
16507 Northcross Dr, Suite F, Huntersville, NC 28078-5082 | |
| (704) 248-0000 | |
| (877) 973-1761 |
| Full Name | Dr Thomas P Stern |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 27 Years |
| Location | 16507 Northcross Dr, Huntersville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083639439 | NPI | - | NPPES |
| 1387E | Other | NC | NCBCBS |
| N01440 | Medicaid | SC | |
| 5901121 | Medicaid | NC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Huntersville Medical Center | Huntersville, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Respiratory And Sleep Medicine, Pllc | 9739228883 | 2 |
News Archive
YM BioSciences Inc., announced the pre-publication of pivotal preclinical data for CYT387, the company's highly selective and potent JAK1/2 inhibitor, currently in a Phase I/II trial for myelofibrosis.
Applied Biosystems, part of Life Technologies Corporation today announced the commercial availability of the SOLiD™ 3 Plus System, an enhanced next-generation genomic analysis platform designed to allow researchers to move one step closer to performing mainstream sequencing of personal genomes for clinical research and personalized medicine.
NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM's enteroendocrine cell program for the treatment of type 2 diabetes and obesity.
Can feeling happy in older age weaken cognition? Is the prevailing drug treatment model for mood disorders the only option? Is chronic sleep deprivation behind the meltdowns we have at home and at work?
A landmark study in mice identifies a biological mechanism that could help explain how tobacco products could act as gateway drugs, increasing a person's future likelihood of abusing cocaine and perhaps other drugs as well, according to the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The study is the first to show that nicotine might prime the brain to enhance the behavioral effects of cocaine.
› Verified 4 days ago
| Entity Name | Advanced Respiratory And Sleep Medicine, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417282039 PECOS PAC ID: 9739228883 Enrollment ID: O20091202000406 |
News Archive
YM BioSciences Inc., announced the pre-publication of pivotal preclinical data for CYT387, the company's highly selective and potent JAK1/2 inhibitor, currently in a Phase I/II trial for myelofibrosis.
Applied Biosystems, part of Life Technologies Corporation today announced the commercial availability of the SOLiD™ 3 Plus System, an enhanced next-generation genomic analysis platform designed to allow researchers to move one step closer to performing mainstream sequencing of personal genomes for clinical research and personalized medicine.
NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM's enteroendocrine cell program for the treatment of type 2 diabetes and obesity.
Can feeling happy in older age weaken cognition? Is the prevailing drug treatment model for mood disorders the only option? Is chronic sleep deprivation behind the meltdowns we have at home and at work?
A landmark study in mice identifies a biological mechanism that could help explain how tobacco products could act as gateway drugs, increasing a person's future likelihood of abusing cocaine and perhaps other drugs as well, according to the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The study is the first to show that nicotine might prime the brain to enhance the behavioral effects of cocaine.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas P Stern, MD 16507 Northcross Dr, Suite F, Huntersville, NC 28078-5082 Ph: (704) 248-0000 | Dr Thomas P Stern, MD 16507 Northcross Dr, Suite F, Huntersville, NC 28078-5082 Ph: (704) 248-0000 |
News Archive
YM BioSciences Inc., announced the pre-publication of pivotal preclinical data for CYT387, the company's highly selective and potent JAK1/2 inhibitor, currently in a Phase I/II trial for myelofibrosis.
Applied Biosystems, part of Life Technologies Corporation today announced the commercial availability of the SOLiD™ 3 Plus System, an enhanced next-generation genomic analysis platform designed to allow researchers to move one step closer to performing mainstream sequencing of personal genomes for clinical research and personalized medicine.
NGM Biopharmaceuticals, Inc. and MedImmune, the global biologics research and development arm of AstraZeneca, announced today that they have entered into an exclusive agreement to discover, develop and commercialize novel therapeutics from NGM's enteroendocrine cell program for the treatment of type 2 diabetes and obesity.
Can feeling happy in older age weaken cognition? Is the prevailing drug treatment model for mood disorders the only option? Is chronic sleep deprivation behind the meltdowns we have at home and at work?
A landmark study in mice identifies a biological mechanism that could help explain how tobacco products could act as gateway drugs, increasing a person's future likelihood of abusing cocaine and perhaps other drugs as well, according to the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. The study is the first to show that nicotine might prime the brain to enhance the behavioral effects of cocaine.
› Verified 4 days ago
Dr. Temple V Day, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 16455 Statesville Rd, Huntersville, NC 28078 Phone: 704-896-2095 Fax: 704-896-0599 | |
Jason Anthony Carnes, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9615 Kincey Ave Ste 210, Huntersville, NC 28078 Phone: 704-489-3113 | |
Alexandria Atuahene Opata, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 16525 Holly Crest Ln Ste 230, Huntersville, NC 28078 Phone: 704-316-6360 Fax: 704-316-6361 | |
Dr. Tiona Kimisha Stephens, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 16224 Hollingbourne Rd, Huntersville, NC 28078 Phone: 954-593-1550 | |
Dr. Yousuf Khan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 16525 Holly Crest Lane, Suite 230, Huntersville, NC 28078 Phone: 704-316-6360 Fax: 704-316-6361 | |
Carly Rivet Hamlin, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 16455 Statesville Rd, Ste 360, Huntersville, NC 28078 Phone: 704-801-3300 |